ALOT Form 4: Director Richard Warzala receives 3,471 restricted shares
Rhea-AI Filing Summary
AstroNova, Inc. (ALOT) director Richard S. Warzala received a restricted stock award of 3,471 shares on 08/28/2025 under the company's Amended and Restated Non-Employee Director Annual Compensation Program. The award was reported as having a price of $0 (restricted grant), and after the transaction the reporting person beneficially owned 67,866 shares. The Form 4 was signed by power of attorney on 09/02/2025. The filing reflects a routine, compensatory equity grant to a non-employee director and does not disclose cash consideration or derivative transactions.
Positive
- Increased insider ownership: Director Richard S. Warzala's beneficial ownership increased to 67,866 shares following the award.
- Compensatory grant aligns interests: The 3,471-share restricted award was granted under the Non-Employee Director Annual Compensation Program, aligning board incentives with shareholders.
Negative
- None.
Insights
TL;DR: Routine director compensation grant increasing insider alignment without disclosed cash payment.
This Form 4 documents a standard restricted stock award to a non-employee director under the company’s board compensation plan. The grant of 3,471 shares increases the director’s stake to 67,866 shares, which can align the director’s interests with shareholders. The award is reported with a $0 price, indicating a restricted compensation grant rather than an open-market purchase. No derivative activity or cash proceeds are shown, and the filing does not disclose vesting terms or potential dilution impact.
TL;DR: Non-material insider grant reported; typical for annual director compensation programs.
The transaction appears to be a compensatory restricted stock award recorded on 08/28/2025. The number of shares (3,471) is modest relative to total outstanding shares for most listed companies, and the report shows beneficial ownership of 67,866 shares post-grant. There is no indication of sales, option exercises, or purchases on the open market. Absent additional context such as vesting schedule or percent of outstanding shares, this filing is informational and likely neutral for valuation.